MedTrace Logo

Single Center Experience Over a Decade in Living Donor Liver Transplantation for Egyptian Patients With Hepatocellular Carcinoma: Stretching the Limits

NCT01937286 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 590

Last updated 2013-09-09

No results posted yet for this study

Summary

Within community with high incidence of HCC, stretching the limits could be justified based on tumor characters and its biological behavior

Conditions

  • Recurrence of HCC After LDLT

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
62 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-01-31
Primary Completion
2011-12-31
Completion
2012-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01937286 on ClinicalTrials.gov